Selected article for: "contact tracing and symptom onset"
Author: Emily R Adams; Rekha Anand; Monique I Andersson; Kathryn Auckland; J Kenneth Baillie; Eleanor Barnes; John Bell; Tamsin Berry; Sagida Bibi; Miles Carroll; Senthil Chinnakannan; Elizabeth Clutterbuck; Richard J Cornall; Derrick W Crook; Thushan De Silva; Wanwisa Dejnirattisai; Kate E Dingle; Christina Dold; David W Eyre; Helen Farmer; Sarah J Hoosdally; Alistair Hunter; Katie Jeffrey; Paul Klenerman; Julian Knight; Clarice Knowles; Andrew J Kwok; Ullrich Leuschner; Chang Liu; Cesar Lopez-Camacho; Philippa C Matthews; Hannah McGivern; Alexander J Mentzer; Jonathan Milton; Juthathip Mongkolsapaya; Shona C Moore; Marta S Oliveira; Fiona Pereira; Timothy Peto; Rutger J Ploeg; Andrew Pollard; Tessa Prince; David J Roberts; Justine K Rudkin; Gavin R Screaton; Malcolm G Semple; Donal T Skelly; Elliot Nathan Smith; Julie Staves; David Stuart; Piyada Supasa; Tomas Surik; Pat Tsang; Lance Turtle; A Sarah Walker; Beibei Wang; Charlotte Washington; Nicholas Watkins; James Whitehouse; Sally Beer; Robert Levin; Alexis Espinosa; Dominique Georgiou; Jose Carlos Martinez Garrido; Hannah Thraves; Elena Perez Lopez; Maria del Rocio Fernandez Mendoza; Alberto Jose Sobrino Diaz; Veronica Sanchez
Title: Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays
  • Document date: 2020_4_20
    • ID: 5trox1i5_31
    Snippet: The copyright holder for this preprint . https://doi.org/10.1101/2020.04. 15.20066407 doi: medRxiv preprint test is currently regarded as a probable surrogate for immunity to reinfection. Secure confirmation of antibody status would therefore reduce anxiety, provide confidence to allow individuals to relax social distancing measures, and guide policy-makers in the staged release of population lock-down, potentially in tandem with digital approach.....
    Document: The copyright holder for this preprint . https://doi.org/10.1101/2020.04. 15.20066407 doi: medRxiv preprint test is currently regarded as a probable surrogate for immunity to reinfection. Secure confirmation of antibody status would therefore reduce anxiety, provide confidence to allow individuals to relax social distancing measures, and guide policy-makers in the staged release of population lock-down, potentially in tandem with digital approaches to contact tracing. 14 As a diagnostic tool, serology may have a role in combination with RT-PCR testing to improve sensitivity, particularly of cases presenting sometime after symptom onset. 15, 16 Reproducible methods to detect and quantify vaccine-mediated anti-SARS-CoV-2 antibodies are also crucial, as vaccines enter clinical trials, evaluating the magnitude and durability of immunogenicity.

    Search related documents:
    Co phrase search for related documents
    • anti SARS and contact tracing: 1, 2, 3, 4, 5, 6, 7
    • anti SARS and diagnostic tool: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • anti SARS and distancing measure: 1, 2
    • anti SARS and durability magnitude: 1, 2, 3, 4
    • anti SARS antibody and clinical trial: 1, 2, 3, 4, 5, 6
    • anti SARS antibody and diagnostic tool: 1, 2, 3
    • anti SARS antibody and distancing measure: 1
    • anti SARS antibody and durability magnitude: 1, 2
    • antibody status and clinical trial: 1
    • antibody status and contact tracing: 1, 2
    • anxiety reduce and clinical trial: 1, 2, 3
    • anxiety reduce and contact tracing: 1
    • anxiety reduce and distancing measure: 1
    • anxiety reduce and population lock: 1
    • clinical trial and contact tracing: 1, 2, 3, 4, 5, 6, 7, 8
    • clinical trial and diagnostic tool: 1, 2
    • clinical trial and digital approach: 1, 2, 3, 4, 5, 6
    • contact tracing and distancing measure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • contact tracing and population lock: 1, 2